Stockreport

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics") and Charles River Laboratories (“Charles River”), a highly respecte [Read more]